Drug boosts survival of patients with form of non-Hodgkin's lymphoma: study

TORONTO (CP) - Adding a new drug to the standard chemotherapy cocktail can significantly boost the survival rate of patients with the most common type of non-Hodgkin's lymphoma - the fastest-rising cancer among Canadians, a study has shown. The study by the B.C....More